| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |